Identification and comparison of aberrant key regulatory networks in breast, colon, liver, lung, and stomach cancers through methylome database analysis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Kim, Byungtak ^a   Kang, Seongeun ^a   Jeong, Gookjoo ^a   Park, Sung Bin ^a   Kim, Sun Jung ^a  

^a Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 2;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL LINE; CARCINOGENESIS; CLUSTER ANALYSIS; COLON CANCER; COMPUTER MODEL; CPG ISLAND; GENE REGULATORY NETWORK; GENETIC ANALYSIS; GENETIC DATABASE; GENOME; HUMAN; HUMAN CELL; LIVER CANCER; LUNG CANCER; METHYLATION; MICROARRAY ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; BREAST TUMOR; CELL LINE; COLON TUMOR; COMPARATIVE STUDY; DNA METHYLATION; GENE EXPRESSION REGULATION; GENETICS; LIVER TUMOR; LUNG TUMOR; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CLUSTER ANALYSIS; COLONIC NEOPLASMS; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICROARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84901312658     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097818     Document Type: Article

References (39)

1. Yokota J (2000) Tumor progression and metastasis. Carcinogenesis 21: 497-503.
2. Yun J, Frankenberger CA, Kuo WL, Boelens MC, Eves EM, et al. (2011) Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO J 30: 4500-4514.
3. Sabater L, Hoftberger R, Boronat A, Saiz A, Dalmau J, et al. (2013) Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer. PLoS One 8: e60438.
4. Easton DF, Bishop DT, Ford D, Crockford GP (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 52: 678-701. (Pubitemid 23310135)
5. Dick FA, Rubin SM (2013) Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol 14: 297-306.
6. Al-Moundhri MS, Al-Ansari A, Al-Mawali K, Al-Bahrani B (2013) BRCA1 gene Molecular Alterations in Omani Breast Cancer Patients. Gulf J Oncolog 1: 45-51.
7. Muller I, Wischnewski F, Pantel K, Schwarzenbach H (2010) Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications. BMC Cancer 10: 297.
8. Barekati Z, Radpour R, Kohler C, Zhang B, Toniolo P, et al. (2010) Methylation profile of TP53 regulatory pathway and mtDNA alterations in breast cancer patients lacking TP53 mutations. Hum Mol Genet 19: 2936-2946.
9. Oliveira AM, Ross JS, Fletcher JA (2005) Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol 124 Suppl: S16-28.
10. Delgado-Cruzata L, Wu HC, Liao Y, Santella RM, Terry MB (2013) Changes in DNA methylation by extent of breast cancer family history in unaffected women. Epigenetics 9.
11. Xu Y, Diao L, Chen Y, Liu Y, Wang C, et al. (2013) Promoter methylation of BRCA1 in triple-negative breast cancer predicts sensitivity to adjuvant chemotherapy. Ann Oncol 24: 1498-1505.
12. Lee SJ, Chae YS, Kim JG, Kim WW, Jung JH, et al. (2013) AQP5 Expression Predicts Survival in Patients with Early Breast Cancer. Ann Surg Oncol.
13. Carney WP, Bernhardt D, Jasani B (2013) Circulating HER2 Extracellular Domain: A Specific and Quantitative Biomarker of Prognostic Value in all Breast Cancer Patients? Biomark Cancer 5: 31-39.
14. Wang YQ, Yan Q, Zhang JR, Li SD, Yang YX, et al. (2013) Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression. J Obstet Gynaecol Res 39: 549-554.
15. Stefansson OA, Jonasson JG, Olafsdottir K, Hilmarsdottir H, Olafsdottir G, et al. (2011) CpG island hypermethylation of BRCA1 and loss of pRb as co-occurring events in basal/triple-negative breast cancer. Epigenetics 6: 638-649.
16. Buckingham L, Penfield Faber L, Kim A, Liptay M, Barger C, et al. (2010) PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer 126: 1630-1639.
17. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, et al. (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69: 2766-2774.
18. Montiel-Duarte C, Cordeu L, Agirre X, Roman-Gomez J, Jimenez-Velasco A, et al. (2008) Resistance to Imatinib Mesylate-induced apoptosis in acute lymphoblastic leukemia is associated with PTEN down-regulation due to promoter hypermethylation. Leuk Res 32: 709-716. (Pubitemid 351330173)
19. Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, et al. (2011) RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer. Cancer Biomark 10: 13-26.
20. Seniski GG, Camargo AA, Ierardi DF, Ramos EA, Grochoski M, et al. (2009) ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma. BMC Cancer 9: 80.
21. Liu Y, Song H, Pan J, Zhao J (2013) Comprehensive gene expression analysis reveals multiple signal pathways associated with prostate cancer. J Appl Genet.
22. Kim SJ, Kelly WK, Fu A, Haines K, Hoffman A, et al. (2011) Genome-wide methylation analysis identifies involvement of TNF-alpha mediated cancer pathways in prostate cancer. Cancer Lett 302: 47-53.
23. Johnson WE, Li C, Rabinovic A (2007) Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8: 118-127. (Pubitemid 44906106)
24. Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, et al. (2012) Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics 7: 502-513.
25. Gu S, Papadopoulou N, Nasir O, Foller M, Alevizopoulos K, et al. (2011) Activation of membrane androgen receptors in colon cancer inhibits the prosurvival signals Akt/bad in vitro and in vivo and blocks migration via vinculin/actin signaling. Mol Med 17: 48-58.
26. Moya P, Esteban S, Fernandez-Suarez A, Maestro M, Morente M, et al. (2013) KiSS-1 methylation and protein expression patterns contribute to diagnostic and prognostic assessments in tissue specimens for colorectal cancer. Tumour Biol 34: 471-479.
27. Mardin WA, Petrov KO, Enns A, Senninger N, Haier J, et al. (2010) SERPINB5 and AKAP12 - expression and promoter methylation of metastasis suppressor genes in pancreatic ductal adenocarcinoma. BMC Cancer 10: 549.
28. Kim JH, Kim TW, Kim SJ (2011) Downregulation of ARFGEF1 and CAMK2B by promoter hypermethylation in breast cancer cells. BMB Rep 44: 523-528.
29. Patsialou A, Wang Y, Lin J, Whitney K, Goswami S, et al. (2012) Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients. Breast Cancer Res 14: R139.
30. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536. (Pubitemid 34130608)
31. Chou HL, Yao CT, Su SL, Lee CY, Hu KY, et al. (2013) Gene expression profiling of breast cancer survivability by pooled cDNA microarray analysis using logistic regression, artificial neural networks and decision trees. BMC Bioinformatics 14: 100.
32. Leroy G, Dimaggio PA, Chan EY, Zee BM, Blanco MA, et al. (2013) A quantitative atlas of histone modification signatures from human cancer cells. Epigenetics Chromatin 6: 20.
33. Hansen KD, Timp W, Bravo HC, Sabunciyan S, Langmead B, et al. (2011) Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43: 768-775.
34. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, et al. (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41: 178-186.
35. Paul I, Savage KI, Blayney JK, Lamers E, Gately K, et al. (2011) PARP inhibition induces BAX/BAK-independent synthetic lethality of BRCA1-deficient non-small cell lung cancer. J Pathol 224: 564-574.
36. Chimonidou M, Strati A, Tzitzira A, Sotiropoulou G, Malamos N, et al. (2011) DNA methylation of tumor suppressor and metastasis suppressor genes in circulating tumor cells. Clin Chem 57: 1169-1177.
37. Yin D, Jia Y, Yu Y, Brock MV, Herman JG, et al. (2012) SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer. Discov Med 14: 33-40.
38. Xu Y, Wei K, Kulyk W, Gong SG (2011) FLRT2 promotes cellular proliferation and inhibits cell adhesion during chondrogenesis. J Cell Biochem 112: 3440-3448.
39. Mayor R, Casadome L, Azuara D, Moreno V, Clark SJ, et al. (2009) Long-range epigenetic silencing at 2q14.2 affects most human colorectal cancers and may have application as a non-invasive biomarker of disease. Br J Cancer 100: 1534-1539.